Outpatient hysteroscopic polypectomy: bipolar energy system (Versapoint®) versus diode laser - randomized clinical trial

Gynecol Endocrinol. 2016;32(3):196-200. doi: 10.3109/09513590.2015.1105209. Epub 2015 Nov 3.

Abstract

Objective: To compare the resection of endometrial polyps with two different devices: the Versapoint biopolar electrode and the Diode Laser.

Methods: One hundred and two patients diagnosed with endometrial polyps were randomly assigned to undergo hysteroscopic polypectomy: one group (n = 52) performed with Versapoint bipolar electrode through a 5Fr working channel and the other group with Biolitec Diode Laser (n = 50) using a specific fiber for polyps in a 7Fr working channel. All cases were managed on an outpatient basis, without anesthesia and using a rigid 30(o) hysteroscope and saline solution as a distention medium.

Main outcome measures: Complete resection rate, operative time, complications, intraoperative pain and relapse rate after three months.

Results: Intraoperative pain and polyp resection time was similar in both groups. Upon second look hysteroscopy at 3-month, a higher percentage of women of the Versapoint group presented polyp relapse (32.6 versus 2.2%, p = 0.001). Elimination of the polyp after incomplete resection was higher in the Laser group. A significantly higher number of patients in the Laser group considered the procedure to be highly recommendable (p = 0.02).

Conclusion: Polypectomy with Diode Laser resulted in fewer relapses and a higher procedure satisfaction rate as compared to Versapoint.

Keywords: Diode Laser; Versapoint; endometrial polyp; hysteroscopy; polypectomy.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Electrosurgery / instrumentation*
  • Female
  • Humans
  • Hysteroscopy / instrumentation*
  • Lasers, Semiconductor / therapeutic use*
  • Middle Aged
  • Polyps / surgery*
  • Uterine Diseases / surgery*